Applications of microarrays with toxicologically relevant genes (tox genes) for the evaluation of chemical toxicants in Sprague Dawley rats in vivo and human hepatocytes in vitro.
暂无分享,去创建一个
Yumiko Sakai | Robin Neft | Usha Sankar | L. Kier | Y. Sakai | Albert P. Li | Albert P Li | R. Neft | Lei Tang | R. Suizu | Tari Cook | Kathy Onsurez | Karen Tiegler | Michael Ortiz | Tim Nolan | Usha Sankar | Larry D Kier | Lei Tang | Robert Suizu | Tari Cook | Kathy Onsurez | Karen Tiegler | Michael Ortiz | Tim Nolan | A. Li
[1] K. Tolman,et al. Hepatotoxicity of the thiazolidinediones. , 2003, Clinics in liver disease.
[2] B. Chabner. Cytotoxic agents in the era of molecular targets and genomics. , 2002, The oncologist.
[3] R. Corvi. Genomics: An In Vitro Toxicology Point of View , 2002, Alternatives to laboratory animals : ATLA.
[4] A. Li,et al. 2,3,7,8 Tetrachlorodibenzo-p-dioxin induction of cytochrome P4501A in cultured rat and human hepatocytes. , 2000, Chemico-biological interactions.
[5] Ben van Ommen,et al. Toxicogenomics of bromobenzene hepatotoxicity: a combined transcriptomics and proteomics approach. , 2003, Biochemical pharmacology.
[6] N. Hewitt,et al. Correlation between troglitazone cytotoxicity and drug metabolic enzyme activities in cryopreserved human hepatocytes. , 2002, Chemico-biological interactions.
[7] J. Waring,et al. The promise of toxicogenomics. , 2002, Current opinion in molecular therapeutics.
[8] Yuichi Sugiyama,et al. Inhibition of Transporter-Mediated Hepatic Uptake as a Mechanism for Drug-Drug Interaction between Cerivastatin and Cyclosporin A , 2003, Journal of Pharmacology and Experimental Therapeutics.
[9] Stephen H. Friend,et al. Toxicogenomics and drug discovery: will new technologies help us produce better drugs? , 2002, Nature Reviews Drug Discovery.
[10] T. Mansfield,et al. Application of toxicogenomics to drug development , 2002, Expert review of molecular diagnostics.
[11] R. Kim,et al. Coordinate induction of both cytochrome P4503A and MDR1 by St John's wort in healthy subjects , 2003, Clinical pharmacology and therapeutics.
[12] G. Orphanides. Toxicogenomics: challenges and opportunities. , 2003, Toxicology letters.
[13] K. Kolaja,et al. Toxicogenomics: an opportunity to optimise drug development and safety evaluation , 2002, Expert opinion on drug safety.
[14] A. Li,et al. Species comparison in P450 induction: effects of dexamethasone, omeprazole, and rifampin on P450 isoforms 1A and 3A in primary cultured hepatocytes from man, Sprague-Dawley rat, minipig, and beagle dog. , 2001, Chemico-biological interactions.
[15] G. L. Kedderis,et al. Present status of the application of cryopreserved hepatocytes in the evaluation of xenobiotics: consensus of an international expert panel. , 1999, Chemico-biological interactions.
[16] C. Mattingly,et al. The Comparative Toxicogenomics Database (CTD). , 2003, Environmental health perspectives.
[17] J. Waring. Development of a DNA Microarray for Toxicology Based on Hepatotoxin-Regulated Sequences , 2002, EHP toxicogenomics : journal of the National Institute of Environmental Health Sciences.
[18] J. Gurwitz,et al. A cohort study of the incidence of serious acute liver injury in diabetic patients treated with hypoglycemic agents. , 2003, Archives of internal medicine.
[19] A. Li,et al. Primary human hepatocytes as a tool for the evaluation of structure-activity relationship in cytochrome P450 induction potential of xenobiotics: evaluation of rifampin, rifapentine and rifabutin. , 1997, Chemico-biological interactions.
[20] W. J. Irwin,et al. Investigation of the coordinated functional activities of cytochrome P450 3A4 and P-glycoprotein in limiting the absorption of xenobiotics in Caco-2 cells. , 2002, Journal of pharmaceutical sciences.
[21] K. Sakurai,et al. Application of Toxicogenomic Analysis to Risk Assessment of Delayed Long-Term Effects of Multiple Chemicals Including Endocrine Disruptors in Human Fetuses , 2003, EHP toxicogenomics : journal of the National Institute of Environmental Health Sciences.
[22] J. Senior,et al. Troglitazone-induced liver failure: a case study. , 2003, The American journal of medicine.
[23] B. Lacarelle,et al. Modulation of MDR1 and CYP3A expression by dexamethasone: evidence for an inverse regulation in adrenals. , 1998, Biochemical and biophysical research communications.
[24] S. Prabhu,et al. Identification of glutathione conjugates of troglitazone in human hepatocytes. , 2002, Chemico-biological interactions.
[25] Christopher J Portier,et al. Toxicogenomics: the new frontier in risk analysis. , 2002, Carcinogenesis.
[26] Mark Cockerill,et al. Genomics and the search for novel biomarkers in toxicology , 2003, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals.
[27] Albert P. Li,et al. A review of the common properties of drugs with idiosyncratic hepatotoxicity and the "multiple determinant hypothesis" for the manifestation of idiosyncratic drug toxicity. , 2002, Chemico-biological interactions.
[28] A. Li,et al. Effects of cytochrome P450 inducers on 17alpha-ethinyloestradiol (EE2) conjugation by primary human hepatocytes. , 1999, British journal of clinical pharmacology.
[29] A. Li,et al. Applications of primary human hepatocytes in the evaluation of pharmacokinetic drug-drug interactions: Evaluation of model drugs terfenadine and rifampin , 1997, Cell Biology and Toxicology.
[30] Richard S Paules,et al. An overview of toxicogenomics. , 2002, Current issues in molecular biology.
[31] M. Relling,et al. P-glycoprotein: a major determinant of rifampicin-inducible expression of cytochrome P4503A in mice and humans. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[32] Chang-Woo Song,et al. cDNA microarray gene expression profiling of hydroxyurea, paclitaxel, and p‐anisidine, genotoxic compounds with differing tumorigenicity results , 2003, Environmental and molecular mutagenesis.
[33] John Lehmann. Toxicogenomics takes center stage. , 2003, Drug news & perspectives.
[34] R. Dunn,et al. Concise review: gene expression applied to toxicology. , 1999, Toxicological sciences : an official journal of the Society of Toxicology.